The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl Metabolite
Abstract
Venlafaxine is a structurally novel, nontricyclic compound that is being evaluated for the treatment of various depressive disorders. A randomized three‐period crossover study was conducted to obtain pharmacokinetic and dose proportionality data on the drug and its active metabolite, O‐desmethylvenlafaxine. Eighteen healthy young men received single doses of venlafaxine 25, 75, and 150 mg followed by 3 days of administration every 8 hours (q8h). Steady‐state elimination half‐life was 3 to 4 hours for venlafaxine and 10 hours for O‐desmethylvenlafaxine; both were independent of dose. Venlafaxine had a high oral‐dose clearance, ranging from 0.58 to 2.63 L/hr/kg across doses with the lowest mean clearance, 0.98 L/hr/kg, at the highest dose. The apparent clearance of O‐desmethylvenlafaxine was lower than venlafaxine, ranging from 0.21 to 0.66 L/hr/kg, and the lowest mean clearance, 0.33 L/hr/kg, occurred at the lowest dose. The area under the metabolite curve was two to three times greater than that for venlafaxine. Each compound had linear dose proportionality up to 75 mg q8h. A composite parameter incorporating venlafaxine plus O‐desmethylvenlafaxine was introduced (i.e., AUC [area under the curve] + activity factor · AUC m), which extended linearity to 150 mg q8h. In summary, venlafaxine is a high‐clearance drug that forms a metabolite with almost equal activity and demonstrates linear dose‐proportionality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90769-0 · Cited by 374
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Confidence Interval Criteria for Assessment of Dose Proportionality
Smith, B. P., Vandenhende, F. R., DeSante, K. A., Farid, N. A., Welch, P. A., Callaghan, J. T., & Forgue, S. T. (2000) · Pharmaceutical Research · doi:10.1023/a:1026451721686 · Cited by 356
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression
Kent, J. M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11381-3 · Cited by 329
Venlafaxine: A Review of its Pharmacology and Therapeutic Potential in Depression
Holliday, S. M., & Benfield, P. (1995) · Drugs · doi:10.2165/00003495-199549020-00010 · Cited by 327
Metadata
- Authors
- Klamerus, K. J., Moloney, K., Rudolph, R. L., Sisenwine, S. F., Jusko, W. J., & Chiang, S. T.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1992-08
- Volume
- 32
- Issue
- 8
- Pages
- 716-724
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W1975588016
- Cited by
- 201
- References
- 1
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl Metabolite. https://app.cochat.ai/papers/10.1002/j.1552-4604.1992.tb03875.x
- The paper
- Klamerus, K. J., Moloney, K., Rudolph, R. L., Sisenwine, S. F., Jusko, W. J., & Chiang, S. T. (1992). Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl Metabolite. The Journal of Clinical Pharmacology. https://doi.org/10.1002/j.1552-4604.1992.tb03875.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.